Showing results (71-80 of 366) with videos related to
Sort By:
Pageof 37
Surgical Oncology Clinics of North America|July 13, 2010
Targeted therapies in early-stage breast cancer: achievements and promisesGeorge W Sledge, Aparna C Jotwani, Lida MinaCancer Research|October 16, 2003
Extracellular proteolysis and cancer: meeting summary and future directionsLynn M Matrisian, George W Sledge, Suresh MohlaCancer|March 22, 2017
Survival benefit needed to undergo chemotherapy: Patient and physician preferencesInes Vaz-Luis, Anne O'Neill, Karen Sepucha, et al.Oncotarget|October 13, 2016
Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African AmericansBryan P Schneider, Dongbing Lai, Fei Shen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2012
Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnosticsDavid R Parkinson, Bruce E Johnson, George W SledgeClinical Advances in Hematology & Oncology : H&O|December 2, 2006
The role of angiogenesis inhibition in the treatment of breast cancerGeorge W Sledge, Hope S Rugo, Harold J BursteinBreast Cancer Research and Treatment|February 6, 2004
Inhibition of breast cancer regrowth and pulmonary metastasis in nude mice by anti-gastric ulcer agent, irsogladineShinichi Nozaki, Mitsuaki Maeda, Hiroyuki Tsuda, et al.Nuclear Medicine and Biology|January 27, 2004
Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4'-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4'-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamideQi Huang Zheng, Xiangshu Fei, Xuan Liu, et al.Nuclear Medicine and Biology|October 17, 2002
Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agentsQi-Huang Zheng, Xiangshu Fei, Xuan Liu, et al.British Journal of Cancer|February 12, 2024
Germline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN 5103 and BEATRICEFei Shen, Guanglong Jiang, Santosh Philips, et al.Pageof 37